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Background: Fibromyalgia syndrome (FS) is characterized by the presence of widespread pain, fatigue, muscle
weakness and reduced work capacity. Previous research has demonstrated that women with fibromyalgia have
altered walking (gait) patterns, which may be a consequence of muscular pain. This altered gait is characterized by
greater reliance on hip flexors rather than ankle plantar flexors and resembles gait patterns seen in normal
individuals walking at higher speeds, suggesting that gait of individuals with fibromyalgia may be less efficient.
This study compared rates of energy expenditure of 6 females with FS relative to 6 normal, age and weight
matched controls, at various walking speeds on a motorized treadmill. Metabolic measurements including V02
(ml/kg/min), respirations, heart rate and calculated energy expenditures as well as the Borg Scale of Perceived
Exertion scale ratings were determined at baseline and for 10 min while walking at each of 2, 4 and 5 km/hour on
1% grade. Kinematic recordings of limb and body movements while treadmill walking and separate measurements
of ground reaction forces while walking over ground were also determined. In addition, all subjects completed the
RAND 36-Item Health Survey (1.0).
Findings: Gait analysis results were similar to previous reports of altered gait patterns in FS females. Despite
noticeable differences in gait patterns, no significant differences (p > 0.05) existed between the FS and control
subjects on any metabolic measures at any walking speed. Total number of steps taken was also similar between
groups. Ratings on the Borg Scale of Perceived Exertion, the RAND and self-reported levels of pain indicated
significantly greater (p < 0.05) perceived effort and pain in FS subjects relative to control subjects during walking
and daily activities.
Conclusions: The altered gait patterns and greater perceptions of effort and pain did not significantly increase the
metabolic costs of walking in women with FS and hence, increased sensations of fatigue in FS women may not be
related to alteration in metabolic cost of ambulation.
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According to the Centers for Disease Control and Preven-
tion [1], fibromyalgia syndrome (FS) is characterized by
the presence of “widespread pain, abnormal pain pro-
cessing, sleep disturbance, fatigue, and often psychological
distress”. Fibromyalgia is a somatic syndrome, which un-
fortunately lacks objective physical features and pathologic
findings. Previous diagnostic criteria for fibromyalgia in-
cluded, “tenderness at 11 or more of the 18 specific tender
point sites” [2], however, recent revisions to the criteria
due to growing concerns about the limited and correct* Correspondence: ptiidus@wlu.ca
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reproduction in any medium, provided the oruse of tender point identification during physical exa-
mination has resulted in this diagnostic criterion being
removed from the American College of Rheumatology’s
diagnostic list [3]. Approximately 2-4% of the population
may have fibromyalgia, it is most common in women, and
generally affects individuals who are middle aged [4].
Several studies have noted significant differences in
gait mechanics and walking strategies in individuals with
fibromyalgia syndrome relative to a normal population.
Pierrynowski et al. [5] found that women with FS had
altered gait patterns, which they may have adopted as a
result of their muscular pain. Gait analysis, from lower
extremity joint kinematics combined with measuring
ground reaction forces while walking at self selectedal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Subject demographics
Fibromyalgia
subjects
Control
subjects
n = 6 n = 6
Age (years) Mean (SD) 47.3 (10.4) 46.2 (9.1)
(Min, Max) (33,57) (35, 57)
Height (cm) Mean (SD) 168 (8.9) 167 (9.1)
(Min, Max) (160, 183) (155, 180)
Weight (kg) Mean (SD) (79.1 21,8) 78.9 (19,5)
(Min, Max) (54.3, 107.5) (57.9, 110.9 )
Length of illness (years) Mean (SD) 10.8 (3.3) n/a
(Min, Max) (6, 15)
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suggested that the gait of individuals with fibromyalgia
may be less efficient than that seen in normal popula-
tions walking at normal speeds. The gait of individuals
with fibromyalgia walking at normal speeds preferen-
tially relied on hip flexors over ankle plantarflexors dur-
ing gait and resembled gait patterns seen in normal
individuals walking at higher rates of speed.
Auvinet et al. [6], conducted a gait analysis study with
14 FS subjects and 14 matched controls. FS walking
speed, cycle frequency, stride length, side-to-side sym-
metry and step regularity was diminished or more poorly
controlled than in matched controls. Overall, FS subjects
were found to walk more slowly, which in turn decreased
stride length and the cycle frequency at self selected pre-
ferred walking speeds.
Using the GAITRite™ system Jiménez et al. [7] repor-
ted that FS subjects demonstrated a significantly higher
double support phase during the walking trials, reduced
walking speed, decreased stride length, swing phase and
single support time. Suggesting impaired gait parameters
perhaps due to factors such as decreased levels of phy-
sical activity, increased body weight, fatigue and pain.
Dal et al. [8] reported similar oxygen cost and con-
sumption for both the FS and control subjects during
walking at self selected walking speeds. This may have
been due to the slower self selected walking speeds
adopted by the FS subjects relative to matched controls.
Dal et al. suggested that the FS subjects were compen-
sating for the pathology in their gait and that the Borg
Scale of Perceived Exertion measures were higher in the
FS subjects relative to controls despite slower walking
speeds [8].
No study has yet compared the metabolic cost of walk-
ing in FS individuals with matched controls at similar
walking speeds to determine if walking efficiency is
influenced by the abnormal gait patterns exhibited in FS
individuals and whether a potential increase in the
energy cost of walking could therefore account for some
of the fatigue reported in FS subjects.
Hence, the objective of this current study was to quan-
tify energy expenditure and gait mechanics of females
with FS relative to normal, age and weight matched con-
trols, at matched slow, normal and fast walking speeds.
It was hypothesized that altered walking patterns in FS
individuals are metabolically more costly than those of
normal individuals walking at matched speeds. If so,
their higher metabolic costs and walking inefficiencies
may partially explain the greater sensations of fatigue
experienced by individuals with fibromyalgia when walk-
ing and performing other simple tasks. These findings
could establish a quantifiable baseline for further research
assessing treatment alternatives for individuals with
fibromyalgia that would: a) attempt to improve their gaitefficiency and reduce their energy expenditure while walk-
ing; and b) provide a quantifiable measure to determine
the degree of gait impairment in individuals with fibro-
myalgia and the effectiveness of any treatment modality in
altering their functional and walking abilities.
The Human Research Ethics Board at Wilfrid Laurier
University provided approval to conduct the study, and
informed consent was obtained from the subjects before
participating in the study. Each subject reported to the
laboratory without having exercised in the previous 24-
hours, and at least four hours following her last meal.
All subjects were required to wear flat-soled sport shoes
throughout the study.
Participants
Females with a confirmed diagnosis of Fibromyalgia
Syndrome (FS) based on criteria established by the
American College of Rheumatology were recruited for
the study utilizing several strategies, including advertise-
ments in two local newspapers, an email advertisement
through a local fibromyalgia support group, and letters
of information to rheumatologists practicing within the
Region of Waterloo. The result was the recruitment of
eight subjects. A convenience sampling method was
used to recruit eight control subjects who were matched
on age (+/−5 years), height (+/−10 cm) and weight
(+/−4 kg) to the FS subjects. Subjects who had a previ-
ous or current injury, impairment and/or deformity of
the lower limb(s) that could impede gait pattern and
ability to walk on a motorized treadmill were excluded
from the study. This resulted in the elimination of two
subjects with FS (and their matched controls); one sub-
ject had a recent ankle injury, and one subject was
scheduled for knee replacement surgery. The final sam-
ple consisted of six subjects with FS and six matched
controls (Table 1). No significant differences (p > 0.05) in
age, height or body weight existed between fibromyalgia
and control groups. Prior to commencing the study, all
subjects completed a brief medical history questionnaire,
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[9], and the RAND 36-Item Health Survey (1.0) [10].
Non-metabolic measurements
RAND 36-item health survey
The RAND 36-Item Health Survey (1.0)5 is an instru-
ment that is based on the Medical Outcomes Study. The
RAND, which consists of 36 closed-ended questions,
measures eight dimensions of health: physical function-
ing (10 items); bodily pain (2 items); role limitations due
to physical health problems (4 items); role limitations
due to personal or financial problems (3 items); emo-
tional well-being (5 items); social functioning (2 items);
energy / fatigue (4 items); and, self-perceptions of health
(5 items); change in health (1 item). The test items for
each dimension are scored and averaged together in
order to create scale scores that can range from 0 to
100. Higher scores represent a higher level of health
function. The survey was completed by each subject
prior to commencing her walking trials on the treadmill.
Self reported level of pain and level of exertion
Using a numerical pain scale (ranging from 0 = no pain,
to 10 = worst pain imaginable), subjects were asked to
self-report the level of pain they experienced on their
best and worst days, as well at baseline and while walk-
ing on the treadmill. Using the Borg Scale of Perceived
Exertion [11] subjects were also asked to rate the per-
ceived level of exertion they experienced in walking on
the treadmill. Pain and exertion data was captured at
baseline and again at minutes 3 and 8 during each of the
three 10-minute walking periods.
Gait analyses / force plate
Gait mechanics and muscle power patterns were deter-
mined by evaluation of kinematic data (OptoTrak 3020,
Northern Digital, Inc, Waterloo, ON, CAN) and ground
reaction forces. Infra-red markers were placed on the
left lateral side of individuals positioned at the joints
of interest (e.g., fifth metatarsal, heel, ankle, knee, hip,
shoulder, elbow, wrist, and temple), to record each joint’s
angular motion during the treadmill walking. Additional
walking trials across a force platform (Advanced Me-
chanical Technology Inc., Watertown, MA, USA) were
recorded in tandem with kinematic data at similar
speeds (within ± 5%) to those of the treadmill walking to
provide force and kinematic data for the calculation of
inverse dynamics to yield individual joint movement,
work, and power profiles, as well as work done on the
body as a whole during the walking cycle. These mea-
surements provided insight as to where the inefficiencies
might be occurring. The techniques have been used in
various previous studies involving older female popula-
tions [12].Metabolic measurements
Direct measure of breath-by-breath oxygen consumption
during rest and at the three walking speeds was assessed
using a computerized Cosmed portable K4b2 metabolic
system. Rate of oxygen uptake at rest and at 3 and 8 min
of walking at each speed was determined and expressed as
ml O2 consumed per kg body weight per minute. Aerobic
energy expenditure expressed as kilocalories per minute
(Kcal/min) was also calculated at these time points from
expired gases using the formula, “3.781 × VO2 + 1.237 ×
VCO2” as assessed by the Cosmed metabolic system and
based on the recommendations of Elia and Livesey [13].
Energy expenditure was also determined per Kg BW. The
K4b2 unit was calibrated prior to use on each subject.
Upon completion of the on ground walking trials, a
latex free facemask, which covered the nose and mouth,
was then applied to the subject. The facemask, which
had ventilation holes, allowed the subject to breathe nor-
mally. The facemask was held in place with a headband
and was secured with Velco straps. The facemask was
connected directly to the K4b2 portable unit, which was
worn in a harness style on the upper back and chest area
and captured each expiratory breath. All breath-by-breath
data were sent to a computer via telemetry. A heart rate
monitor was also applied around the upper torso, slightly
below the sternum. Baseline metabolic measurements
were made for 10 minutes on subjects while they were
seated quietly.
At the end of the baseline period, the markers that were
used during the initial gait analyses were checked to en-
sure that correct placement had been maintained; subjects
were then placed on a motor driven treadmill. Breath-by-
breath analyses continued while subjects walked for ten
minutes on the treadmill at a 1% grade at each of 2 km/
hour (slow walking), 4 km/hour (normal walking), and
5 km/hour (fast walking). The markers captured the sub-
jects’ gait position at minutes 3 and 8 during each of the
ten-minute walking periods. For safety purposes each sub-
ject was equipped with an emergency release device,
which was attached to both the subject and the treadmill.
If the connection between the emergency release device
and the subject was broken, the treadmill was program-
med to automatically stop. Because the first FS subject
was unable to walk on the treadmill without holding onto
at least one handrail due to a fear of falling, all remaining
subjects (FS and control) were instructed to keep their
right hand on the right handle of the treadmill throughout
the testing period in order to maintain a consistent and
controlled trial.
Participants
FS Subjects
With respect to the medical history of the subjects with FS,
one subject reported that she suffered from hypertension,
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one other subject reported that she suffered from asthma.
Three subjects indicated that they had been previously
diagnosed with either osteopenia, osteoarthritis, or arth-
ritis. Three subjects reported a remote history of hip, knee,
or ankle injuries, which at the time of study did not impair
their ability to ambulate. None of the subjects reported a
history heart disease, diabetes, stroke, or prosthetic limbs.
When asked if they were taking any medications (including
prescription, over the counter, natural, homeopathic, and
herbal remedies), all subjects responded in the affirmative.
Prescriptions medications that were noted as being taken
in the FS group were from the following pharmaceutical
classes: analgesic (non-narcotic); analgesic (narcotic); anti-
depressant; antiemetic; anti-estrogen; anti-inflammatory;
anxiolytic; bronchodilator; sedative / hypnotic; and, thy-
roid hormone. Of note, is that only one subject reported
taking prescription narcotic analgesics for pain associated
with her FS; the remaining subjects reported using prod-
ucts that did not contain narcotics (e.g., Extra-Strength
Tylenol™, Advil™, Ibuprofen™). Excluding over-the-counter
analgesics, the most frequently reported non-prescription
medications were vitamins and folic acid. All subjects
were non-smokers. Two subjects reported that they were
physically active on a daily basis, whereas the remaining
subjects indicated they did not participate in physical
activity at all.
Matched control subjects
Two of the control subjects reported they suffered from
asthma, one subject reported she had both heart disease
and hypertension, and three subjects reported they suf-
fered from migraine headaches. None of the control sub-
jects had a history of diabetes, stroke, prosthetic limbs,
skeletal disease (e.g., osteopenia) or rheumatoid condition
(e.g., arthritis, osteoarthritis). Three subjects reported a
remote history of knee and/or ankle injuries, which at the
time of study did not impair their ability to ambulate. The
most commonly prescribed medications included anti-
depressants, anti-hypertensives, antilipid, and bronchodi-
lators. The most commonly reported over-the-counter
(non-prescription) medications included analgesics and
vitamins. Three subjects reported that they were smokers.
Two subjects reported being physically active one to
two times per week, while the remaining four subjects
reported that they did not participate in physical activity.
Data analyses
Univariate statistical procedures were used to provide
descriptive overviews of both the non-metabolic mea-
sures (i.e., RAND, self-reported levels of pain, self-
reported levels of exertion, and number of steps taken
while walking on the treadmill) and metabolic measures
of interest (i.e., V02, V02/kg, respirations, heart rate,EEm, EEbsa, EEkg, and METS). In light of the small
sample size, analyses at the bivariate level were com-
pleted using non-parametric statistical tests (Wilcoxon
Rank Sum Test) [14] in order to identify significant
differences between the two groups of subjects. To calcu-
late joint powers, ground reaction forces were recorded
in conjunction with kinematics during the over-ground
walking trials. The joint powers were calculated using
procedures outline in Winter [15].
Non-metabolic measurements
RAND 36-item health survey (Version 1.0)
With the exception of three dimensions (e.g., role limita-
tions due to emotional problems, emotional well being,
and, general health), significant (P < 0.01) differences
between the two groups of subjects were noted on the
remaining five dimensions, pain, physical health, energy/
fatigue, physical functioning and role limitations due to
physical health. In each of dimensions the FS group scores
were significantly higher than the controls indicating
greater fatigue, pain and functional limitations.
Self-report measurement of pain
Using a numerical pain scale of 0-10, where 0 was
equated with ‘no pain’ and 10 was the ‘worst pain
imaginable’, subjects were asked the following two ques-
tions: a) “On days when you are feeling your best, how
would you rate your pain?”, and, b)”On days when you
are feeling your worst, how would you rate your pain?”
On both pain dimensions the FS subjects scored signifi-
cantly (P < 0.01) higher than the controls (mean ± SD.
fibromyaliga vs control: best days 3.1 ± 1.5 vs 0.0 ± 0.4,
worst days 9.5 ± 0.8 vs 3.0 ± 2.9). Using the same numer-
ical rating scale, subjects were then asked to report their
level of pain at minutes 3 and 8 during baseline and at
each of the three 10-minute walking periods on the
treadmill. Again the FS subjects reported significantly
(P < 0.01) higher pain at each of the walking time points.
The fibromyalgia subject’s pain scores progressed from
means of 3.8 to 5.75 as the walking speeds increased
while the control subjects reported pain (0.0) at any of
the walking speeds.
Self-reported level of exertion
At various time points throughout the study, the Borg
Scale of Perceived Exertion was used to have the sub-
jects rate their perceived levels of exertion between 0
(nothing at all) and 10 (very, very hard). Subjects were
asked to report their level of exertion at minutes 3 and 8
during each of the three 10-minute walking periods on
the treadmill. At each of the walking speeds the FS sub-
jects reported significantly (P < 0.01) greater perceived
exertion than the control subjects progressing from
means of 3.0 to 5.8 as walking speed and time increased
Table 2 Comparison of hip power to ankle power during
the end of the stance phase
Fibro (n =5) Control (n = 2)
Hip power (W/kg) 1.146 (0.379) 0.768 (0.658)
Ankle power (W/kg) 0.639 (0.589) 1.325 (0.399)
Ankle/hip power ratio 0.558 1.725
Data were scaled and normalized.
Note: Due to technical issues joint powers in several of the control participants
were not calculated.
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progressing from means of 1.0 to 2.0 as walking speed
and time increased.
Gait analyses: total steps taken
The following table summarizes the data related to the
total number of steps that each subject took during the
walking trial on the treadmill. There was no significant dif-
ference between the two groups on this measure (P > 0.05).Figure 1 Representative hip and ankle power for repeated trails (vert
participants.Gait analyses: hip and ankle power
Table 2 provides a summary of the hip and ankle power
for the FS and control subjects. Figure 1 depicts repre-
sentative ankle and hip power for repeated trials of a FS
and control subject.
Metabolic measurements
Tables 3 and 4 provides a summary of the mean (SD), and
range (minimum, maximum) for the values of V02 /kg
(ml/min/kg) and calculated energy expenditure (Kcal/
min) respectively, which were captured at the 3 and 8
minute time points at baseline and while subjects walked
for ten minutes on the treadmill at a 1% grade at each of
2 km/hour (slow walking), 4 km/hour (normal walking),
and 5 km/hour (fast walking). Respiration, heart rate, and
calculated energy expenditure in metabolic equivalents
(METS) were also determined but exhibited no significant
differences (P > 0.05) between the two groups of subjects
(data not shown). Despite noticeable differences in gaitical lines represent standard error) of control and fibromyalgia
Table 3 V02 /kg (ml/min/kg)
Subject type Baseline Baseline 2 km 2 km 4 km 4 km 5 km 5 km
(3 min.) (8 min) (3 min.) (8 min.) (3 min.) (8 min.) (3 min.) (8 min.)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
(Min, Max) (Min, Max) (Min, Max) (Min, Max) (Min, Max) (Min, Max) (Min, Max) (Min, Max)
FS 3.2 3.9 6.7 8.3 10.0 11.0 11.8 12.2
(1.1) (2.7) (3.7) (3.1) (3.4) (3.0) (2.3) (5.6)
(1.93,4.75) (1.3,8.5) (1.4,12.6) (5.2,13.3) (7.4,16.4) (7.8,15.5) (9.8,13.3) (9.2,16.5)
Controls 2.71 2.6 7.3 7.0 9.1 9.1 11.3 11.7
(0.8) (0.8) (2.1) (1.9) (1.8) (1.5) (2.4) (1.6)
(1.7,4.0) (2.1,4.1) (5.2,10.8) (5.1,9.2) (6.711.1) (7.2,11.1) (8.7,12.6) (10.0,14.7)
Wilcoxon rank sum test p = n.s p = n.s. p = n.s. p = n.s. p = n.s. p = n.s. p = n.s. p = n.s.
(p > .29) (p > .34) (p > .41) (p > .30) (p > .47) (p > .12) (p > .35) (p > .41)
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tween the fibromyalgia subjects and the control subjects
in oxygen consumption (ml/kg/min) or calculated energy
expenditure (Kcal/min) at either of the 3 or 8 min time
points at any of the walking speeds. Energy expenditure
while walking expressed as Kcal/min.kg BW (data not
shown) also did not result in any significant (P > 0.05)
differences between groups at any of the time points or
walking speeds.
Availability of supporting data
No significant differences in oxygen consumption or
calculated energy costs were seen between female FS
subjects and age and weight matched controls at three
different walking speeds despite significant differences in
gait mechanics and higher levels of pain, perceived
exertion and discomfort reported in FS subjects. It is
possible that the differences in gait mechanics between
our groups were not of sufficient magnitude to signifi-
cantly alter energy expenditure and oxygen consumptionTable 4 EEm (Kcal/min)
Subject type Baseline Baseline 2 km
(3 min.) (8 min) (3 min.)
Mean (SD) Mean (SD) Mean (SD) M
(Min, Max) (Min, Max) (Min, Max) (M
FS 1.17 1.5 2.45
(0.4) (1.2) (1.19)
(0.9, 1.72) (0.5, 3.8) (0.5, 3.8)
Controls 1 1.0 2.8
(0.3) (0.4) (0.9)
(0.7, 1.5) (0.5, 1.2) (1.5, 3.6)
Wilcoxon rank sum test p = n.s. p = n.s. p = n.s.
(p > .19) (p > .35) (p > .35)measures between groups. Although technical difficulties
limited the numbers of subjects whose gait could be com-
pletely analyzed, results from our study did suggest that
the gait mechanics differed between groups in a manner
similar to that previously reported by Pierrynowski et al.
[5]. The joint power results in this study demonstrated the
same increased reliance, in the fibromyalgia participants,
on hip power in relationship to ankle power as found in a
previous study by Pierrynowski et al. [5]. These differences
did not result in significant differences in oxygen con-
sumption or energy expenditure at matched slow or faster
walking speeds. Although various other clinical popula-
tions have reported greater energy expenditure due to
altered gait mechanics, such findings are not universal
[16] and at least one other study has reported a lack of
difference in energy expenditure at self selected walking
speeds between FS and control subjects [8] Hence, altered
gait mechanics in women with FS may not account for the
increased fatigue expressed by the subjects with FS based
on any significant differences in energy expenditure or2 km 4 km 4 km 5 km 5 km
(8 min.) (3 min.) (8 min.) (3 min.) (8 min.)
ean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
in, Max) (Min, Max) (Min, Max) (Min, Max) (Min, Max)
3.1 3.7 4.1 4.5 4.4
(1.0) (0.9) (1.1) (1.0) (1.9)
(1.9, 4.8) (2.6, 4.9) (2.8, 6.1) (3.4 6.1) (3.4, 5.0)
2.7 3.5 3.6 4.4 4.6
(0.8) (1.0) (101) (1.3) (1.3)
(1.6, 3.4) (2.3, 4.3) (2.2 4.9) (2.6, 5.8) (3.0, 6.2)
p = n.s. p = n.s. p = n.s. p = n.s. p = n.s.
(p > .41) (p > .40) (p > .35) (p > .53) (p > .24)
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daily fatigue in women with FS relative to controls may
not be related to differences in energy expenditure while
walking. Alternatively, although not measured in this
study, local muscle fatigue due to altered gait mechanics
may have been greater in the FS subjects relative to con-
trols, possibly contributing to fatigue and pain sensations.
Given that there was no significant differences between
the groups with respect to oxygen consumption or energy
expenditure while walking it may be that, FS feel more
“fatigued” in part because FS is accompanied by increased
sensations of local and global muscle pain.
Several limitations in the study may have influenced
our results. All subjects were unfamiliar with the walk-
ing surface; therefore all subjects were required to hold
onto the treadmill handle with their right hand (so as
not to interfere with the markers on the left side of the
body where the biomarkers had been placed). This
additional support may have had minor influences on
the altered gait patterns, oxygen consumption and
energy expenditure measures relative to free walking.
Two of the FS subjects reported that they exercised on a
regular basis. In light of the small sample size, their
higher level of physical fitness may have skewed the
metabolic measurements for the group of FS subjects.
As noted by Water and Mulroy [16] increased cardio-
vascular fitness in clinical populations with altered gait
patterns, may lead to an increased ability to tolerate
higher rates of energy consumption in order to maintain
a more normal walking speed. Additionally, regular exer-
cise will result in enhanced well being and reduced
muscle pain in FS subjects [17]. The time spent walking
on the treadmill (at each speed and overall) was rela-
tively short and as such, we might not have been able to
readily capture metabolic changes that might have been
manifested in longer walking trials that could have
induced greater fatigue. The simplified marker setup
may have introduced some minor error with regard to
calculating the ankle and hip powers, however the
results were very similar to the Pierrynowski et al. [5]
study on a similar population. Additionally, a relatively
small sample size may have possibly influenced the gait
and energy expenditure results; however, strong agree-
ment with earlier gait data was demonstrated and little
difference was noted between groups in energy expend-
iture and oxygen consumption. Nevertheless, a wider
sample size of FS subjects may have produced a greater
variation in energy expenditure with possibly some
subjects exhibiting greater differences from controls.
Further research will be required with larger subject
populations to further verify our initial findings.
Within these potential limitations of the study, we
found that female FS subjects did not demonstrate
significantly greater oxygen consumption or energyexpenditure during treadmill walking at slower or
faster speeds than age and weight matched normal
controls despite significant differences in gait mechan-
ics and greater discomfort and fatigue during walking
or daily life. Hence, energy expenditure during walk-
ing may not explain differences in fatigue or discom-
fort experienced by FS individuals relative to normal
controls.
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